Visible Light‐Induced Pigmentation: Improved In Vivo Methodology for Measuring Efficacy of 30 Products in 9 Randomised Controlled Trials and Correlation With In Vitro Assessment
Experimental Dermatology · 2025
DOI: 10.1111/exd.70167 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Experimental Dermatology, 2025. Verfasst von Pascale Renoux und 8 weiteren Autor:innen. Beteiligte Einrichtung: L'Oréal Research and Innovation, Chevilly Larue, France. Hauptthemen laut MEDLINE: Sunscreening Agents, Light, Skin Pigmentation, Hyperpigmentation. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
As hyperpigmentation can worsen with exposure to ultraviolet (UV) and visible light (VL), sunscreens with well‐balanced UVB/UVA protection and VL‐blocking pigments are recommended. Assessing efficiency against VL‐induced pigmentation is then mandatory. Recently, an in vivo pigmentation assessment allowing a VL protection factor (pVL‐PF) determination, and an in vitro predictive method based on transmittance measures were introduced. However, the number of volunteers, tested sunscreens, and protection range were limited. Moreover, no statistical assessment was associated. This study aimed at testing the robustness and improving these methodologies by conducting a series of 9 monocentric, double‐blind, randomised controlled in vivo studies involving 188 volunteers and 30 products, alongside an in vitro approach, in 2 independent laboratories. Our results first allowed us to improve pVL‐PF calculation by better fitting to VL‐induced pigmentation dynamics. Based on the 30 established pVL‐PF, we evidenced that VL‐protection level strongly correlated with the amount of pigments in products. Second, a statistical Bayesian approach, accounting for kinetic and inter‐individual response variability over time, was proposed. This enabled us to determine that 24 out of 30 products significantly reduced VL‐induced pigmentation. Finally, we showed that in vitro transmittance reduction was highly predictive of in vivo results. In conclusion, through several independent studies involving a large number of products and volunteers, a refined pVL‐PF calculation associated with statistical indicators was proposed together with a predictive in vitro assessment. These methodologies to assess the efficacy of tinted products against VL‐induced pigmentation are complementary and could also be of interest for other pathologies induced or aggravated by VL. Trial Registration: NCT06827392, NCT06796192, NCT06803901, NCT06796140, NCT06796153, NCT06796010, NCT06796088, NCT06796205, NCT06796179
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- L'Oréal Research and Innovation, Chevilly Larue, France.
- L'Oréal Research and Innovation, Aulnay sous Bois, France.
- Cencora-PharmaLex Belgium, Mont-Saint-Guibert, Belgium.
ORCID-Profile: Hussein Jouni, Clément Laloux, Claire Marionnet
Zitieren
APA
Renoux, P., Jouni, H., Laloux, C., Touti, R., Vieu, D. L., Lamarche, F., Santos, S. M., Bernerd, F., & Marionnet, C. (2025). Visible Light‐Induced Pigmentation: Improved In Vivo Methodology for Measuring Efficacy of 30 Products in 9 Randomised Controlled Trials and Correlation With In Vitro Assessment. Experimental Dermatology. https://doi.org/10.1111/exd.70167
Vancouver
Renoux P, Jouni H, Laloux C, Touti R, Vieu DL, Lamarche F, et al. Visible Light‐Induced Pigmentation: Improved In Vivo Methodology for Measuring Efficacy of 30 Products in 9 Randomised Controlled Trials and Correlation With In Vitro Assessment. Experimental Dermatology. 2025. doi:10.1111/exd.70167
BibTeX
@article{Renoux2025,
author = {Renoux, Pascale and Jouni, Hussein and Laloux, Clément and Touti, Rita and Vieu, Diane-Lore and Lamarche, François and Santos, Silvia Morim and Bernerd, Françoise and Marionnet, Claire},
title = {Visible Light‐Induced Pigmentation: Improved In Vivo Methodology for Measuring Efficacy of 30 Products in 9 Randomised Controlled Trials and Correlation With In Vitro Assessment},
journal = {Experimental Dermatology},
year = {2025},
doi = {10.1111/exd.70167}
}
EUVIMED